247
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Gene Expression of Human Beta-Defensin-3 and Cathelicidin in the Skin of Leprosy Patients, Household Contacts, and Healthy Individuals from Indonesia

ORCID Icon, ORCID Icon, ORCID Icon &
Pages 1485-1492 | Received 25 Jan 2023, Accepted 30 May 2023, Published online: 12 Jun 2023

References

  • Salgado CG, de Brito AC, Salgado UI, Spencer JS. Leprosy. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, editors. Fitzpatrick’s Dermatology. 9th ed. New York: McGraw-Hill Education; 2019:2892–2954.
  • Pusat Data dan Informasi Kementerian Kesehatan RI. Profil Kesehatan Indonesia [Internet]. Kementerian Kesehatan RI; 2021. Available from: https://pusdatin.kemkes.go.id/folder/view/01/structure-publikasi-pusdatin-profil-kesehatan.html. Accessed June 2, 2023.
  • Bryceson A, Pfaltzgraff RE. Clinical pathology. In: Leprosy. 3rd ed. London: Churchill Livingstone; 1990:11–24.
  • Schreuder PAM, Noto S, Richardus JH. Epidemiologic trends of leprosy for the 21st century. Clin Dermatol. 2016;34(1):24–31. doi:10.1016/j.clindermatol.2015.11.001
  • Lastória JC, de Abreu MAMM. Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - Part 1. An Bras Dermatol. 2014;89(2):205–218. doi:10.1590/abd1806-4841.20142450
  • World Health Organization. Global Leprosy Update, 2018: Moving Towards a Leprosy- Free World. Vol. 94. Geneva: World Health Organization; 2019:389–412.
  • Doull JA. The incidence of leprosy in Cordova and Talisay, Cebu, Philippines. Int J Lepr. 1942;10:107–131.
  • Sansonetti P, Lagrange PH. The immunology of leprosy: speculations on the leprosy spectrum. Rev Infect Dis. 1981;3(3):4222–4469. doi:10.1093/clinids/3.3.422
  • Cogen AL, Walker SL, Roberts CH, et al. Human beta-defensin 3 is up-regulated in cutaneous leprosy type 1 reactions. PLoS Negl Trop Dis. 2012;6(11):e1869. doi:10.1371/journal.pntd.0001869
  • Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003;3(9):710–720. doi:10.1038/nri1180
  • Semple F, Webb S, Li HN, et al. Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo. Eur J Immunol. 2010;40(4):1073–1078. doi:10.1002/eji.200940041
  • Matzner M, Al Samie AR, Winkler HM, et al. Low serum levels of cathelicidin LL-37 in leprosy. Acta Trop. 2011;117(1):56–59. doi:10.1016/j.actatropica.2010.09.007
  • Lee JY, Suh JS, Kim JM, et al. Identification of a cell-penetrating peptide domain from human beta-defensin 3 and characterization of its anti-inflammatory activity. Int J Nanomedicine. 2015;10:5423–5424. doi:10.2147/IJN.S90014
  • Pinheiro RO, Schmitz V, de Andrade Silva BJ, et al. Innate immune responses in leprosy. Front Immunol. 2018;9:518. doi:10.3389/fimmu.2018.00518
  • Abulafia J, Vignale RA. Leprosy: pathogenesis updated. Int J Dermatol. 1999;38(5):321–334. doi:10.1046/j.1365-4362.1999.00650.x
  • Bayal N, Nagpal S, Haque MM, et al. 16S rDNA based skin microbiome data of healthy individuals and leprosy patients from India. Sci Data. 2019;6(225):1–9. doi:10.1038/s41597-019-0232-1
  • de Naves M, delRibeiro FA, Patrocino LG, Patrocino JA, Fleury RN, Goulart IMB. Bacterial load in the nose and its correlation to the immune response in leprosy patients. Lepr Rev. 2013;84(1):85–91. doi:10.47276/lr.84.1.85
  • Masaki T, McGlinchey A, Cholewa-Waclaw J, Qu J, Tomlinson SR, Rambukkana A. Innate immune response precedes Mycobacterium leprae-induced reprogramming of adult Schwann cells. Cell Reprogram. 2014;16(1):9–17. doi:10.1089/cell.2013.0064
  • van Hooij A, Tió-Coma M, Verhard EM, et al. Household contacts of leprosy patients in endemic areas display a specific innate immunity profile. Front Immunol. 2020;11:1811. doi:10.3389/fimmu.2020.01811
  • Zhao Z, Mu ZL, Liu XW, et al. Expressions of antimicrobial peptides LL-37, human beta defensin-2 and −3 in the lesions of cutaneous tuberculosis and tuberculids. Chin Med J. 2016;129(6):696–701. doi:10.4103/0366-6999.178011
  • Izadpanah A, Gallo RL. Antimicrobial peptides. J Am Acad Dermatol. 2005;52(3 Pt 1):381–390. doi:10.1016/j.jaad.2004.08.026
  • Zhang LJ, Gallo RL. Antimicrobial peptides. Curr Biol. 2016;26(1):R14–R19. doi:10.1016/j.cub.2015.11.017
  • Bardan A, Nizet V, Gallo RL. Antimicrobial peptides and the skin. Expert Opin Biol ther. 2004;4(4):543–549. doi:10.1517/14712598.4.4.543
  • Romero-Montoya M, Beltran-Alzate JC, Cardona-Castro N, Johnson C. Evaluation and monitoring of Mycobacterium leprae transmission in household contacts of patients with Hansen’s disease in Colombia. PLoS Neglk Trop Dis. 2017;11(1):e0005325. doi:10.1371/journal.pntd.0005325
  • Wittersheim M, Cordes J, Meyer-Hoffert U, Harder J, Hedderich J, Gläser R. Differential expression and in vivo secretion of the antimicrobial peptides psoriasin (S100A7), RN ase 7, human beta‐defensin‐2 and‐3 in healthy human skin. Exp Dermatol. 2013;22(5):363–366. doi:10.1111/exd.12133
  • Godal T, Lofgren M, Negassi K. Immune response to M. leprae of healthy leprosy contacts. Int J Lepr Other Mycobact Dis. 1972;40(3):243–250.
  • Kenshi Y, Gallo RL. Antimicrobial peptides in human skin disease. Eur J Dermaol. 2008;18(1):11–21.
  • Li T, Guo F, Wang Q, et al. N-terminus three residues deletion mutant of human beta-defensin 3 with remarkably enhanced salt-resistance. PLoS One. 2015;10(2):e0117913. doi:10.1371/journal.pone.0117913
  • Harder J, Schröder JM. Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J Leukoc Biol. 2005;77(4):476–486. doi:10.1189/jlb.0704409
  • Maier T, Guell M, Serrano L. Correlation of mRNA and protein in complex biological samples. FEBS Letter. 2009;583:3966–3973. doi:10.1016/j.febslet.2009.10.036